Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
24,513,814
Value
$1.37B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,513,814$1.37B0.1%−638,428−2.5%ReducedHolders
Q1 202625,152,242$1.21B0.1%−1,120,066−4.3%ReducedHolders
Q4 202526,272,308$1.02B0.1%−1,714,406−6.1%ReducedHolders
Q3 202527,986,714$987.4M0.1%−12,371,107−30.7%ReducedHolders
Q2 202540,357,821$1.45B0.1%+953,728+2.4%AddedHolders
Q1 202539,404,093$1.23B0.1%+13,024,760+49.4%AddedHolders
Q4 202426,379,333$672.9M<0.1%−1,510,810−5.4%ReducedHolders
Q3 202427,890,143$789.0M<0.1%+3,4420.0%AddedHolders
Q2 202427,886,701$735.4M<0.1%−5,747,515−17.1%ReducedHolders
Q1 202433,634,216$1.02B0.1%+2,050,287+6.5%AddedHolders
Q4 202331,583,929$887.2M0.1%+1,156,757+3.8%AddedHolders
Q3 202330,427,172$825.8M0.1%−3,457,078−10.2%ReducedHolders
Q2 202333,884,250$1.04B0.1%−6,099,866−15.3%ReducedHolders
Q1 202339,984,116$1.44B0.1%−4,126,249−9.4%ReducedHolders
Q4 202244,110,365$1.74B0.2%+1,152,485+2.7%AddedHolders
Q3 202242,957,880$1.73B0.2%+7,004,526+19.5%AddedHolders
Q2 202235,953,354$1.51B0.2%+7,748,193+27.5%AddedHolders
Q1 202228,205,161$1.10B0.1%+6,125,366+27.7%AddedHolders
Q4 202122,079,795$879.9M0.1%+2,970,038+15.5%AddedHolders
Q3 202119,109,757$690.6M0.1%−4,986,172−20.7%ReducedHolders
Q2 202124,095,929$987.7M0.1%−3,856,891−13.8%ReducedHolders
Q1 202127,952,820$1.22B0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.